References
[1]. Butt ZA, Gilani AH, Nanan D, Sheikh AL, and White F.
(2005). “Quality of pharmacies in Pakistan: A crosssectional
survey”. International Journal for Quality in Health
Care, Vol.17, No.4, pp.307-13.
[2]. Hafeez A, Kiani AG, Din Su, Muhammad W, Butt K, Shah
Z, et al. (2004). “Prescription and Dispensing Practices in
Public Sector Health Facilities in Pakistan-Survey Report”.
Journal of Pakistan Medical Association, Vol.54, No.4,
pp.187-91.
[3]. Bott RF, Oliveira WP. (2007). “Storage conditions for
stability testing of pharmaceuticals in hot and humid
regions”. Drug Development and Industrial Pharmacy,
Vol.33, No.4, pp.393-401.
[4]. Syhakhang L, Freudenthal S, Tomson G and Wahlstrom
R. (2004). “Knowledge and perceptions of drug quality
among drug sellers and consumers in Lao PDR”. Health Policy and Planning, Vol.19, No.6, pp.391-401.
[5]. Okeke CC, Bailey L, Medwick T, and Grady LT. (2000).
“Revised USP standards for product dating, packaging, and
temperature monitoring”. American Journal of Health-
System Pharmacy, Vol.57, No.15, pp.1441-5.
[6]. Alam MT, and Aftab K. (1996). “Quality Assurance and
Good Manufacturing Practices”. Pakistan Journal of
Pharmaceutical Sciences, Vol.9, No.2, pp.69-31.
[7]. Du B, Daniels VR, Vaksman Z, Boyd JL, Crady C, Putcha
L. (2011). “Evaluation of physical and chemical changes in
pharmaceuticals flown on space missions”. The AAPS
Journal, Vol.13, No.2, pp.299-308.
[8]. Abegunde D. (2013). Essential Medicines for Non-
Communicable Diseases (NCDs) and Pharmaceutical
Policies by WHO. Essential Medicines and Health Products
Information Portal.
[9]. Arshad A, Riasat M, and Mahmood MKT, (2011). “Drug
Storage Conditions in Different Hospitals in Lahore”. Journal
of Pharmaceutical Sciences and Technology, Vol.3, No.1,
pp.543-47.
[10]. WHO (1996). Expert Committee on Specifications for
Pharmaceutical Preparations. Thirty-Fourth Report.
Geneva, World Health Organization. WHO Technical Report
Series, 863.
[11]. Good Storage Practice, (1980). “Joint report of the
Committee for Official Laboratories and Medicinal Control
Services and the Industrial Pharmacists Section of the
International Pharmaceutical Federation (FIP)”. Pharm Ind.
Vol.42, pp.1082-5.
[12]. Quality Assurance of Pharmaceuticals, (1999). “A
compendium of guidelines and related materials”. Good
Manufacturing Practices and Inspection, Geneva, World
Health Organization. Vol.2.
[13]. Good Trade and Distribution Practice (GTDP) of
pharmaceutical starting materials. Geneva, World Health
Organization, (unpublished document QAS/01.014;
available on request from Essential Drugs and Medicines
Policy, World Health Organization, 1211 Geneva 27,
Switzerland). 2002.
[14]. WHO, (n.d.). Expert Committee on Specifications for
Pharmaceutical Preparations. Thirty-fourth report. Geneva, World Health Organization. WHO Technical Report Series.
1996;863.
[15]. “Good manufacturing practices for pharmaceutical
products”. In: Quality Assurance of Pharmaceuticals: A
Compendium of Guidelines and Related Materials,
Volume 2. Good manufacturing practices and inspection.
Geneva, World Health Organization, 1999; WHO Expert
Committee on Specifications for Pharmaceutical
Preparations. Thirty-Fifth report. Geneva, World Health
Organization. WHO Technical Report Series. 1999(885).
[16]. Adhikari R, Soonthorndhada K, and Prasartkul P.
(2009). “Correlates of unintended pregnancy among
currently pregnant married women in Nepal”. BMC
International Health and Human Rights. Vol.9, No.1, pp.17.
[17]. The International Pharmacopoeia, 3rd ed. Vol. 1:
General methods of analysis; Vol. 2: Quality specifications;
Vol. 3: Quality specifications; Vol. 4: Tests, methods, and
general requirements. Quality specifications for
pharmaceutical substances, excipients, and dosage
forms; Vol.5: Test and general requirements for dosage
forms. Quality specifications for pharmaceutical
substances and tablets (in press). Geneva, World Health
Organization, 1979 - 2002.
[18]. Islam MM, and Rashid M. (2005). “Determinants of
unintended pregnancy among ever-married women in
Bangladesh”. Journal of Family Welfare, Vol.50, No.2,
pp.40.
[19]. N.C. Obitte AC, D.C. Odimegwu and V.C. Nwoke.
(2009). “Survey of drug storage practice in homes, hospitals
and patent medicine stores in Nsukka, Nigeria”. Scientific
Research and Essay, Vol.4, No.11, pp.1354-9.
[20]. Dodo ANO, S H. (2002). “Medicine safety in West
Africa”. West African Journal of Pharmacy, Vol.16, No.1,
pp.1-4.
[21]. The Uppsala Monitoring Centre, (2000). WHO
collaborating Centre for International Drug Monitoring.
Safety Monitoring of Medicinal Products: Guidelines for
Setting up and Running a Pharmacovigilance Centre.
[22]. Thome J-M, and Pholsena S. (2009). “Lao People's
Democratic Republic: Health financing reform and
challenges in expanding the current social protection schemes”. Promoting Sustainable Strategies to Improve
Access to Health Care in the Asian and Pacific Region,
pp.71-102.
[23]. Bardin C, Astier A, Vulto A, Sewell G, Vigneron J, Trittler
R, et al., (2011). “Guidelines for the practical stability studies
of anticancer drugs: A European consensus conference”.
Annales Pharmaceutiques francaises: Elsevier, Vol.69,
No.4, pp.221-231.
[24]. Bell KN, Hogue CJR, Manning C, and Kendal AP.
(2001). “Risk factors for improper vaccine storage and
handling in private provider offices”. Pediatrics, Vol.107,
No.6, pp.100-e.
[25]. Azhar Hussain Mimi. (2011). “Qualification, knowledge
and experience of dispensers working at community
pharmacies in Pakistan”. Pharm Pract (Granada), Vol.9,
No.2, pp.93-100.
[26]. Syhakhang L. (2002). “The quality of private pharmacy
services in a province of Lao PDR: Perceptions, practices
and regulatory enforcements”. Division of International
Health/Department of Public Health Sciences.
[27]. Zaidi S, Nishtar NA and Nourneen, (2013). “Rational
Prescription & Use: A Snapshot of the Evidence from
Pakistan and Emerging Concerns”. International Journal of
Pharmacy and Pharmaceutical Sciences, Vol.5, No.1,
pp.131-135.
[28]. Wtto Portal, (2003). Guidelines for the Storage of
Essential Medicines and Other Health Commodities.
[29]. Nogueira FHA, Moreira-Campos LM, Santos RLCd,
and Pianetti GA, (2011). “Quality of essential drugs in
tropical countries: Evaluation of antimalarial drugs in the
Brazilian Health System”. Revista da Sociedade Brasileira
de Medicina Tropical, Vol.44, No.5, pp.582-6.
[30]. Sabine Kopp, (2006). “Stability testing of
pharmaceutical products in a global environment”. Regul
Aff J, pp.291-4.
[31]. Crichton B. (2004). “Keep in a cool place: exposure of
medicines to high temperatures in general practice during
a British heatwave”. JRSM. Vol.97, No.7, pp.328-9.
[32]. Bawazir SA. (2004). “Consumer attitudes towards
community pharmacy services in Saudi Arabia”.
International Journal of Pharmacy Practice, Vol.12, No.2, pp.83-9.
[33]. Qadwai W et al., (2006). “Private drug sellers
education in improving prescribing practices”. J Col Physic
Surg Pak, Vol.16, pp.743-6.
[34]. Patel KT, and Chotai NP. (n.d.). “Pharma science
monitor”. Int J Pharm Sci, pp.1980-93.
[35]. Pau AK, Moodley NK, Holland DT, Fomundam H,
Matchaba GU, and Capparelli EV. (2005). “Instability of
lopinavir/ritonavir capsules at ambient temperatures in sub-
Saharan Africa: Relevance to WHO antiretroviral
guidelines”. Aids, Vol.19, No.11, pp.1233.
[36]. Hogerzeil HV, Battersby A, Srdanovic V, and
Stjernstrom NE. (2005). “Stability of essential drugs during
shipment to the tropics”. BMJ: British Medical Journal,
Vol.304, No.6821, pp.210.
[37]. Haworth EA, Booy R, Stirzaker L, Wilkes S, and
Battersby A. (1992). “Is the cold chain for vaccines
maintained in general practice?”, BMJ: British Medical
Journal. Vol.307, No.6898, pp.242.
[38]. Colero MD. (2012). Storage of Medicines and
Medical Products.
[39]. Butt ZA GA, Nanan D, Sheikh AL, and White F. (2005).
“Quality of pharmacies in Pakistan: A cross-sectional
survey”. International Journal for Quality in Health Care,
Vol.17, No.4, pp.307-13.
[40]. Mahbub-ul-Haq. (1998). Human Development in
South Asia. Oxford University Press, Karachi.
[41]. S F-P. (2002). Human Development Report,
Deepening Democracy in a Fragmented World. New York:
Oxford University Press.
[42]. Hafeez-ur-Rahman, (1999). Manual of Drug Laws
nd 1999. Pioneer Book House, 2 ed. Karachi.
[43]. Organization. WH. (2000). Role of Dispensers in
Promoting Rational Drug Use.
[44]. Corelli RL, Zillich AJ, de Moor C, Giuliano MR, Arnold J,
Fenlon CM, et al. (2013). “Recruitment of community
pharmacies in a randomized trial to generate patient
referrals to the tobacco quitline”. Research in Social and
Administrative Pharmacy. Vol.9, No.4, pp.396-404.
[45]. Rafie S, Kim GY, Lau LM, Tang C, Brown C, and Maderas NM. (2013). “Assessment of Family Planning
Services at Community Pharmacies in San Diego,
California”. Pharmacy, Vol.1, No.2, pp.153-9.
[46]. Farris KB F-LF, Benrimoj SIC. (2005). “Pharmaceutical
care in community pharmacies: Practice and research
from around the world”. Annals of Pharmacotherapy,
Vol.39, No.9, pp.1539-41.
[47]. Blenkinsopp A, Anderson C and Armstrong M. (2003).
“Systematic review of the effectiveness of community
pharmacy-based interventions to reduce risk behaviours
and risk factors for coronary heart disease”. Journal of
Public Health, Vol.25, No.2, pp.144-53.
[48]. The NHS Information Centre, (2012). General
Pharmaceutical Services in England 2001-02 to 2010-11.
London: The Health and social Care Information Centre.
Retrieved from: http://www.ic.nhs.uk/statistics-and-datacollections/
primary-care/pharmacies.
[49]. Adepu R NB. (2006). “General practitioners'
perceptions about the extended roles of the community
pharmacists in the state of Karnataka: A study”. Ind J
Pharma Sci., Vol.68, pp.36-40.
[50]. Viberg N. (2009). “Selling Drugs or Providing Health
Care?: The role of private pharmacies and drugstores,
examples from Zimbabwe and Tanzania”. Division of
Global Health/Department of Public Health Sciences.
[51]. Hussain A, and Ibrahim MIM. (2011). “Perceptions of
Dispensers regarding dispensing practices in Pakistan: A
Qualitative Study”. Tropical Journal of Pharmaceutical
Research, Vol.10, No.2.
[52]. Taylor J. (2001). “Recommendations on the control
and monitoring of storage and transportation
temperatures of medicinal products”. The Pharmaceutical
Journal, Vol.267, No.28, pp.128-31.
[53]. Jacobs S, Hassell K, Ashcroft D, Johnson S, and
Connor E. (2014). “Workplace stress in community
pharmacies in England: Associations with individual,
organizational and job characteristics”. Journal of Health
Services Research & Policy. Vol.19, No.1, pp.27-33.
[54]. Astin JA. (1998). “Why patients use alternative
medicine: results of a national study”. JAMA, Vol.279,
No.19, pp.1548-53.
